Skip to main content
Top
Literature
1.
2.
go back to reference Sakkinen P, Abbott RD, Curb JD, Rodriguez BL, Yano K, Tracy RP (2002) C-reactive protein and myocardial infarction. J Clin Epidemiol 55:445–451CrossRefPubMed Sakkinen P, Abbott RD, Curb JD, Rodriguez BL, Yano K, Tracy RP (2002) C-reactive protein and myocardial infarction. J Clin Epidemiol 55:445–451CrossRefPubMed
3.
go back to reference Nakanishi S, Yamane K, Kamei N, Okubo M, Kohno N (2003) Elevated C-reactive protein is a risk factor for the development of type 2 diabetes in Japanese Americans. Diabetes Care 26:2754–2757CrossRefPubMed Nakanishi S, Yamane K, Kamei N, Okubo M, Kohno N (2003) Elevated C-reactive protein is a risk factor for the development of type 2 diabetes in Japanese Americans. Diabetes Care 26:2754–2757CrossRefPubMed
4.
go back to reference Kawada T, Otsuka T, Katsumata M, Suzuki H (2006) Association between components of the metabolic syndrome and serum levels of C-reactive protein in Japanese workingmen. J Cardiometab Syndr 1:168–172CrossRefPubMed Kawada T, Otsuka T, Katsumata M, Suzuki H (2006) Association between components of the metabolic syndrome and serum levels of C-reactive protein in Japanese workingmen. J Cardiometab Syndr 1:168–172CrossRefPubMed
5.
go back to reference Wu WT, Tsai SS, Shih TS, Lin MH, Chou TC, Ting H, Wu TN, Liou SH (2015) The impact of obstructive sleep apnea on high-sensitivity C-reactive protein in subjects with or without metabolic syndrome. Sleep Breath 19:1449–1457. doi:10.1007/s11325-015-1166-2 Wu WT, Tsai SS, Shih TS, Lin MH, Chou TC, Ting H, Wu TN, Liou SH (2015) The impact of obstructive sleep apnea on high-sensitivity C-reactive protein in subjects with or without metabolic syndrome. Sleep Breath 19:1449–1457. doi:10.​1007/​s11325-015-1166-2
6.
go back to reference Araújo Lda S, Fernandes JF, Klein MR, Sanjuliani AF (2015) Obstructive sleep apnea is independently associated with inflammation and insulin resistance, but not with blood pressure, plasma catecholamines, and endothelial function in obese subjects. Nutrition 31:1351–1357CrossRefPubMed Araújo Lda S, Fernandes JF, Klein MR, Sanjuliani AF (2015) Obstructive sleep apnea is independently associated with inflammation and insulin resistance, but not with blood pressure, plasma catecholamines, and endothelial function in obese subjects. Nutrition 31:1351–1357CrossRefPubMed
Metadata
Title
Inflammatory markers in patients with obstructive sleep apnea
Author
Tomoyuki Kawada
Publication date
01-05-2016
Publisher
Springer Berlin Heidelberg
Published in
Sleep and Breathing / Issue 2/2016
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-015-1302-z

Other articles of this Issue 2/2016

Sleep and Breathing 2/2016 Go to the issue

Sleep Breathing Physiology and Disorders • Original Article

Rates of initial acceptance of PAP masks and outcomes of mask switching

Sleep Breathing Physiology and Disorders • Original Article

Missing teeth and pediatric obstructive sleep apnea

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine